Geneesmiddelenbeleid
This procedure concerns a rapporteur's report regarding pharmaceutical policy in the Netherlands. It aims to address the framework governing the development, regulation, and distribution of medicines to ensure public health standards are met. The report affects pharmaceutical companies, healthcare providers, and patients within the Netherlands by shaping how medicines are managed and accessed.
National vote coverage: Netherlands-only